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A b s t r a c t
Background: Epicardial adipose tissue (EAT) is thought to be associated with the extension and severity of coronary artery 
disease (CAD), and echocardiographic measurement of EAT thickness is considered to be a possible cardiovascular risk indica-
tor. The European Society of Cardiology Task Force recommends further non-invasive testing in patients with an intermediate 
pre-test probability (PTP) for the diagnosis of CAD. 
Aim: We sought to evaluate the clinical usefulness of performing EAT measurements in patients with a high-intermediate PTP.
Methods: Patients referred to an outpatient clinic with stable chest pain symptoms, with PTP for CAD between 66% and 85%, 
were included in the study. Echocardiographic measurement of the EAT was identified as the echo-free space between the 
outer wall of the myocardium and the visceral layer of the pericardium. Single-photon emission computed tomography (SPECT) 
was performed in all patients. The diagnosis of CAD was based on the presence of reversible perfusion defects on SPECT.
Results: A total of 126 patients (76 men, 60.3%) with a mean age of 65.3 ± 9.1 years were recruited. The EAT thickness was 
7.3 ± 0.7 mm in patients with positive SPECT and 6.2 ± 0.6 mm in patients with negative SPECT (p < 0.001). Multivariable 
analysis revealed higher rates of positive SPECT in patients with higher EAT (odds ratio [OR] 9.80; 95% confidence interval 
[CI] 3.72–25.79; p < 0.001), and receiver operating characteristic curve analysis showed that the greatest specificity was 
obtained when the cut-off value of EAT thickness was 6.75 mm (sensitivity 76%; specificity 74%).
Conclusions: In patients with high-intermediate PTP, EAT is a useful measurement that may assist in risk stratification. 
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INTRODUCTION
Epicardial adipose tissue (EAT) is an accumulation of true 
visceral fat surrounding the heart, especially along the major 
branches of the coronary arteries. EAT directly reflects the 
deposition of the visceral adipose tissue that is related to 
a cardiometabolic risk profile. It is an extremely active tissue, 
rich in free fatty acids, with various secretory functions such 
as expression of higher levels of pro-atherogenic interleukin 6 
mRNA and depletion of anti-atherogenic adiponectin mRNA [1]. 
Because epicardial fat and myocardium share the same micro-
circulation, these inflammatory signals are thought to induce 
atherogenic changes in the coronary arteries by modifying 
vascular homeostasis, promoting endothelial dysfunction, and 
aggravating vascular inflammation [2, 3].
Accordingly, epicardial fat is thought to be associated with 
coronary flow reserve, subclinical atherosclerosis, and exten-
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sion and severity of coronary artery disease (CAD) [4–6]. Thus, 
echocardiographic measurement of EAT thickness has been 
considered as a possible indicator of cardiovascular risk [7].
The precise usage of non-invasive cardiac investigations 
in supporting the diagnosis of CAD can only be established in 
connection with  pre-test probability (PTP). PTP is the clinical 
possibility that a given patient will develop CAD, based on 
simple clinical clues, as well as the prevalence of CAD in the 
assessed population. Also, to achieve post-test probability of 
CAD  for a given patient, pre-test estimates and the results of 
non-invasive cardiac test should be evaluated together. Inap-
propriate testing may cause harm because of a higher chance 
of false test results. Based on the assumption that patients with 
a low PTP (< 15%) have no obstructive CAD and patients 
with a high PTP (> 85%) have obstructive CAD, the European 
Society of Cardiology (ESC) Task Force recommends further 
non-invasive testing in patients with an intermediate PTP of 
15% to 85% [8]. Moreover, guidelines uphold imaging stress 
test as the initial test for the diagnosis of CAD in patients 
with a high-intermediate PTP of 66% to 85% [8]. A resting 
transthoracic echocardiography is also recommended in all 
patients with a high-intermediate PTP for either diagnostic or 
risk stratification purposes.
The purpose of this study was to assess the clinical useful-
ness of echocardiographic EAT measurements in patients with 
a high-intermediate PTP. 
METHODS
Patient population
The study population consisted of patients referred to an out-
patient clinic with stable chest pain symptoms. Inclusion crite-
ria comprised PTP between 66% and 85% for stable CAD after 
clinical assessment on the basis of sex, age, and symptoms [8]. 
A total of 126 (76 men, 60.3%) consecutive symptomatic 
patients with no previous history of overt atherosclerotic dis-
ease (cerebral, peripheral, or CAD, which was defined as any 
degree of CAD on previous angiogram or history of myocardial 
infarction, revascularisation, or angina), heart failure, and renal 
impairment (creatinine level > 1.4 mg/dL) were recruited. 
We excluded patients with uncontrolled hypertension, poor 
echocardiographic imaging, prosthetic heart valve, pericar-
dial effusion, moderate to severe valvular disease, stroke, 
and unstable angina pectoris. Complete medical history was 
obtained and detailed physical examination was performed 
in all patients. Blood pressure was measured in the supine 
position after 10-min rest. Anthropometric characteristics 
were measured, and body mass index (BMI) was calculated as 
weight/height squared (kg/m2). Blood samples were taken for 
haematological and biochemical evaluation. Calcium channel 
blockers and b-blockers, if used, were discontinued for 48 h, 
and all patients were prepared for myocardial perfusion imag-
ing for evaluation of possible CAD symptoms. Clinical model 
of PTP was used for CAD in our study population. Informed 
consent was obtained from all patients, and the investigation 
conformed to the principles of the Declaration of Helsinki. The 
study protocol was approved by the Local Ethical Committee. 
Myocardial perfusion imaging study
To evaluate the presence of ischaemic heart disease, all pa-
tients underwent myocardial perfusion single-photon emission 
tomography (SPECT) imaging using a one-day gated single 
isotope 99mTc-sestamibi stress/rest protocol, as suggested in 
the guidelines [9]. Treadmill ergometry using standard proto-
cols was achieved for stress imaging unless physical exercise 
was not possible or insufficient. In such case, pharmacologi-
cal stress test induced with intravenous adenosine (dose of 
140 µg/kg per min for 6 min) was used either alone or com-
bined with physical stress. The images at rest and during stress 
were gathered using a Siemens Multispect 2HD/HD gamma 
camera (Siemens, Stokesdale, NC, USA). A positive test was 
defined as the presence of reversible perfusion defects on 
visual inspection located in any of the myocardial territories 
during stress.
Echocardiographic measurement
A complete transthoracic echocardiography using a 3.5-MHz 
transducer (Vivid 7, GE-Vingmed Ultrasound AS, Horten, Nor-
way) was carried out in each patient. EAT was identified as the 
echo-free space between the outer wall of the myocardium 
and the visceral layer of the pericardium, and its thickness 
was measured on the free wall of the right ventricle from 
the parasternal long- and short-axis views according to the 
method previously described [10]. The maximum EAT was 
calculated at the point on the free wall of the right ventricle 
at end-systole, and measurements were done perpendicu-
larly to the aortic annulus for the parasternal long-axis view 
and perpendicularly to the interventricular septum at the 
mid-chordal and tip of the papillary muscles level for the 
parasternal short-axis view (Fig. 1). The mean value of the 
two measurements was used to reflect the thickness the EAT. 
The echocardiograms were performed before the SPECT 
imaging, and both procedures were performed by the same 
operator. The average value of three consecutive cardiac cy-
cles from each echocardiographic view was studied. To test 
the reproducibility of EAT measurement, the measurement 
was repeated one week later in 20 patients.
Statistical analysis
Categorical and numerical variables are shown as percentage 
and mean ± standard deviation, respectively. Descriptive 
statistics was used for definition of clinical and social demo-
graphic variables. Kolmogorov-Smirnov test was used to test 
the normality of the variances. Numerical variables were 
tested with unpaired Student t test, and categorical variables 
were tested using c2 test. Spearman’s test was used for correla-
tion analysis. Receiver operating characteristic (ROC) curve 
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analysis was performed to identify the optimal cut-off value 
of EAT thickness (at which sensitivity and specificity would 
be maximal) for the prediction of ischaemia-positive SPECT. 
Sensitivity, specificity, and positive and negative predictive 
values of the obtained EAT cut-off value for ischaemia-positive 
SPECT were calculated. Multiple logistic regression analysis 
using the backward logistical regression method was applied 
to determine the best predictor(s) that affected mortality after 
adjustment for all possible confounding factors. Any variable 
with a p value < 0.25 in a univariate test was accepted as 
a candidate for a multivariable analysis, along with all variables 
of known clinical importance. Odds ratios (ORs) and 95% 
confidence intervals (CIs) for each independent variable were 
also calculated. A p value < 0.05 was considered significant. 
All the statistical tests were done using SPSS 16.0 (SPSS Inc., 
Chicago, IL, USA).
RESULTS
Mean EAT thickness was 6.6 ± 0.8 mm (range 4.8–9.4 mm). 
The intraobserver, intraclass correlation coefficient for EAT 
measurement was 0.86. Heredity for CAD was 29% within 
the study population. A total of 41 patients were using oral 
anti-diabetics and 22 patients were on insulin treatment. 
CAD was diagnosed based on SPECT. SPECT was positive for 
ischaemia in 39 (31.0%) of the 126 patients. Thirteen patients 
had > 10% inducible ischaemia in SPECT. Exercise SPECT was 
performed in 46 (36.5%) patients. Patients with pathological 
results of the perfusion study had a difference in high-density 
lipoprotein cholesterol and total cholesterol levels, systolic 
blood pressure, and BMI (Table 1). Among ischaemia-positive 
patients there was a higher ratio of smokers and patients with 
hypertension (Table 1). The EAT thickness in patients with 
ischaemia-positive SPECT was significantly greater than in 
patients with ischaemia-negative SPECT. The EAT thickness 
was 7.3 ± 0.7 mm in patients with ischaemia-positive SPECT 
and 6.2 ± 0.6 mm in patients with ischaemia-negative SPECT 
(p < 0.001) (Fig. 2).
Results of univariate and multivariable analyses are shown 
in Table 2. Variables with a significant p value in univariate 
analysis were included into multivariable analysis. Accord-
ing to the results of the multivariable regression analysis, 
epicardial adipose tissue was an independent predictor (OR 
9.80; 95% CI 3.72–25.79; p < 0.001) of ischaemia-positive 
SPECT along with systolic blood pressure (OR 1.01; 95% CI 
1.00–1.02; p = 0.03) and BMI (OR 1.51; 95% CI 1.13–2.02; 
p = 0.005). The correlations between EAT thickness and 
waist circumference, BMI, high-density lipoprotein level, 
systolic blood pressure, heart rate, presence of diabetes mel-
litus, and inducible ischaemia ratio are presented in Table 3. 
Correlation analysis of the epicardial adipose tissue and the 
inducible ischaemia ratio in SPECT was performed by the 
Spearman’s rank correlation test and presented on a scat-
terplot (r: 0.703, p < 0.001; Fig. 3). ROC analysis showed 
that the best cut-off value of the EAT thickness to ischaemia in 
SPECT was 6.75 mm with 76% sensitivity and 74% specificity 
(area under curve 0.85; 95% CI 0.78–0.92; p < 0.001; Fig. 4).
DISCUSSION
In this study, we prospectively examined the predictive value 
of echocardiographic EAT for the presence of perfusion defects 
diagnosed by SPECT in symptomatic patients with high-inter-
mediate (66%–85%) PTP. The EAT in the present study was 
Figure 1. Arrows showing epicardial fat thickness measured by echocardiography in the parasternal short-axis (A) and long-axis 
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with ischaemia-positive SPECT. Although this finding is in ac-
cordance with the literature [11], the range and mean value of 
EAT found in this study are in fact higher due to higher mean 
age and higher pre-test probabilities for CAD in the patients, 
and the fact that documented ischaemia was considered as 
the outcome. Also, Nelson et al. [5] concluded that a greater 
burden of EAT measured by echocardiography would identify 
individuals at increased risk for cardiovascular events, and 
higher cut-off values of EAT were consistently identified in 
higher-risk groups within their cohort. 
Results of our study are consistent with a previous 
study [12], which showed that EAT is an independent factor 
related to the presence of CAD, which is significantly and 
proportionally increased according to the extent of cardiac 
fat deposition. Other studies declared that EAT significantly 
correlated with severe multiple of coronary artery stenosis 
and identified EAT as a marker of severity of coronary lesions 
[13, 14]. Measurements of EAT in those studies were done 
either in patient populations with low PTP, in patients with 
acute coronary syndrome and/or chronic stable angina re-
ferred for coronary angiography, or in patients with an abnor-
mal results of the stress test. However, uniquely, the present 
study evaluates the EAT in patients with high-intermediate 
PTP and its relation to the presence of reversible perfusion 
defects on SPECT.
Table 1. Characteristics of patients positive and negative for ischaemia in single-photon emission computed tomography (SPECT)
SPECT ischaemia (–) (n = 87) SPECT ischaemia (+) (n = 39) p 
Age [years] 65.4 ± 8.8 65.3 ± 10.0 0.950
Male sex 53 (61%) 23 (59%) 0.830
Diabetes mellitus 31 (35%) 18 (46%) 0.260
Hypertension 23 (26%) 20 (51%) 0.007
Smoking 40 (46%) 26 (66%) 0.030
Family history of CAD 24 (27%) 13 (33%) 0.510
Heart rate [bpm] 76.7 ± 8.8 80.1 ± 9.2 0.050
Body mass index [kg/m2] 30.1 ± 2.6 31.7 ± 2.3 0.002
Systolic blood pressure [mmHg] 121.1 ± 14.4 132.1 ± 12.9 0.010
Diastolic blood pressure [mmHg] 81.5 ± 9.0 82.3 ± 7.9 0.160
Triglyceride [mg/dL] 131.5 ± 43.8 139.2 ± 34.9 0.346
Total cholesterol [mg/dL] 212 ± 56.2 231.2 ± 49.5 0.020
LDL cholesterol [mg/dL] 145.3 ± 38.2 141 ± 27.4 0.380
HDL cholesterol [mg/dL] 39.9 ± 8.6 45.5 ± 8 0.070
Height [cm] 165.9 ± 5.4 168.1 ± 7.0 0.080
Weight [kg] 83.0 ± 7.5 89.7 ± 7.8 0.001
Waist circumference [cm] 90.7 ± 5.2 91.6 ± 6.3 0.370
Ejection fraction [%] 61.2 ± 5.2 60.0 ± 4.0 0.233
Mean EAT [mm] 6.2 ± 0.6 7.3 ± 0.7 < 0.001
Data are shown as mean ± standard deviation or number (percentage). CAD — coronary artery disease; EAT — epicardial adipose tissue;  
HDL — high-density lipoprotein; LDL — low-density lipoprotein
Figure 2. Distribution of the epicardial adipose tissue (EAT) 
thickness in patients positive and negative for ischaemia in myo-
cardial perfusion imaging study (single-photon emission compu-
ted tomography [SPECT], myocardial perfusion imaging study)
greater in the group of patients with ischaemia-positive SPECT. 
We found EAT measurement to be 7.3 ± 0.7 mm in patients 
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Because inflammatory mediators originating outside 
the coronary artery are capable of promoting compositional 
changes in the inner layer of intima, EAT produces a local 
proatherosclerotic effect by means of paracrine and vasocrine 
secretions of inflammatory adipokines [15, 16]. Age and obesi-
ty, by increasing fat mass or fat tissue redistribution to the trunk 
and viscera, are important determinants of EAT. Although it is 
found to be related with cardiovascular and metabolic risk fac-
tors, as in our study [17], a study by Nelson et al. [5] revealed 
a weak correlation between EAT and Framingham risk score 
and no correlation with subclinical atherosclerosis assessed 
by carotid intima-media thickness, carotid artery plaque, and 
coronary artery calcium score. However, recently Canpolat 
et al. [18] clarified that EAT measured by echocardiography 
independently predicted the AF recurrence after cryoabla-
tion and was also positively correlated with high-sensitivity 
C-reactive protein as an indicator of systemic inflammation. 
This discrepancy may be due to the different nature of study 
populations. Also, Ding et al. [19] supported the idea that 
epicardial fat is a better predictor of incident coronary heart 
disease than more general measures of adiposity such as BMI 
or waist circumference. 
Furthermore, we investigated the cut-off level of mean 
EAT for identifying the presence of perfusion defects. In the 
Table 3. Spearman rank correlation (R) between epicardial 
adipose tissue (EAT) and waist, body mass index (BMI), high- 
-density lipoprotein (HDL), systolic blood pressure (SBP), heart 
rate, presence of diabetes mellitus (DM), and inducible  
ischaemia ratio
Variable R p
EAT and waist 0.297 < 0.001
EAT and BMI 0.308 < 0.001
EAT and HDL 0.388 < 0.001
EAT and SBP 0.324 < 0.001
EAT and heart rate 0.300 < 0.001
EAT and presence of DM 0.276 < 0.001
EAT and inducible ischaemia ratio 0.703 < 0.001
Table 2. Univariate predictors and multivariable model for ischaemia-positive single-photon emission computed tomography
Univariate analysis p Multivariable analysis p OR (95% CI)
Height* 0.061
Weight* < 0.001
EAT < 0.001 EAT < 0.001 9.80 (3.72–25.79)
HDL 0.001
Total cholesterol 0.075






BMI 0.002 BMI 0.005 1.51 (1.13–2.02)
All clinically relevant parameters were included in the model. Only parameters that reached statistical significance in univariate analysis were given 
in the leftmost column. *These parameters were not included in the multivariable model as they are components of BMI. BMI — body mass index; 
CI — confidence interval; EAT — epicardial adipose tissue; HDL — high-density lipoprotein; OR — odds ratio; SBP — systolic blood pressure
Figure 3. Correlation analysis of the epicardial adipose tissue 
(EAT) and the inducible ischaemia ratio in single-photon 
emission computed tomography (SPECT) performed by the 
Spearman rank correlation test and presented by using scatter 
dot analysis (r: 0.703, p < 0.001) 
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Figure 4. Receiver operating characteristic curve analysis  
identifying ischaemia-positive myocardial perfusion imaging 
study. The cut-off value of mean epicardial adipose tissue 
thickness was set at 6.75 mm; AUC — area under curve;  
CI — confidence interval
setting of patients with PTP between 66% and 85%, when the 
cut-off value of mean EAT was set at 6.75 mm, it had 76% 
sensitivity and 74% specificity for the indication of ischae-
mia. Mustelier et al. [12] found that EAT ≥ 5.2 mm in systole 
had 65.4% sensitivity and 61.5% specificity for predicting 
CAD, and Eroglu et al. [20] found that an EAT thickness of 
5.2 mm in diastole had 85% sensitivity and 81% specificity 
for predicting the presence of CAD in symptomatic subjects 
undergoing coronary angiography. In those studies the pres-
ence of CAD was defined as one or more stenosis ≥ 50% in 
diameter and ≥ 20% in diameter (for the latter) of a major 
epicardial vessel. However, we found that an EAT thick-
ness of 6.75 mm in diastole had 76% sensitivity and 74% 
specificity for the indication of active myocardial ischaemia 
on nuclear perfusion scanning. Recently, Khawaja et al. [21] 
demonstrated a selective increase of epicardial fat volume 
(EFV) measured by computed tomography (CT) in regions 
of myocardial ischaemia detected by myocardial perfusion 
imaging; but regions of myocardium with normal perfusion 
or myocardial scarring were characterised by lower EFV [21]. 
In addition, Uygur et al. [22] reported that left atrioventricular 
groove EFV measured by contrast-enhanced CT was an inde-
pendent predictor of CAD in type 2 diabetic patients without 
a history of CAD. Recently, Tabakci et al. [23] showed that 
EAT was inversely correlated with functional status and dis-
ease severity in patients with heart failure. Furthermore, EFV 
assessed by CT was an independent predictor of ischaemia 
on positron emission tomography in correlation with interme-
diate PTP of CAD. Also, the EAT preferential increase along 
non-calcified, vulnerable plaque lesions was compared to 
chronically calcified coronary lesions [24]. To our knowledge, 
the present study is the first to show the association between 
EAT measured by echocardiography and inducible myocardial 
perfusion. Besides obstructive coronary plaques, EAT may also 
affect myocardial perfusion by inducing endothelial damage, 
microvascular dysfunction, and deterioration of coronary 
flow via exacerbated inflammatory milieu. EAT is consist-
ently associated with CAD, and the incidence of significant 
coronary artery stenosis increased in proportion to the EAT 
despite varying methodologies and study populations. In the 
future, EAT thickness measurements may play an important 
role in the clinical practice of patients with high-intermediate 
pre-test probability of CAD. Our results support the role of 
echocardiographic EAT quantification in risk stratification of 
patients with high-intermediate PTP.
Our sample size was relatively small and did not in-
clude patients with acute coronary syndrome and patients 
with low PTP. Secondly, echocardiographic measurement 
may not completely reflect epicardial fat distribution when 
compared to magnetic resonance imaging or CT because of 
its three-dimensional distribution. Another limitation of our 
study is the fact that although we planned to include patients 
with a pre-test probability of 66% to 85%, only 31% of them 
had ischaemia-positive SPECT results. This may be due to the 
dynamic nature of ischaemia detected by SPECT not reflecting 
silent lesions. Furthermore, absence of universal coronary an-
giography and coronary flow reserve quantification confined 
us to validate the asserted mechanisms. Finally, the lack of 
prospective follow-up is another limitation of our study.
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